| Name: | Clindamycin Sulfoxide Impurity |
| Catalogue No. | VL1030006 |
| CAS No. | 22431-46-5 |
| Molecular Formula | C18H33ClN2O6S |
| Molecular Weight | 440.98 |
| Status | In-stock |
| IUPAC Name | 7-Chloro-1,6,7,8-tetradeoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-(methylsulfinyl)-L-threo-α-D-galactooctopyranose |
| Appearance | Off White powder |
| Description | Clindamycin Sulfoxide Impurity (CAS No: 22431-46-5) is a chemical transformation of Clindamycin. Clindamycin is often evaluated in the treatment of erythromycin-resistant Staphylococcus aureus which causes skin and soft tissue infections. Clindamycin is also useful as an anti-malarial drug. |
| References | Koba, Olga, et al. “Antibiotics Degradation in Soil: A Case of Clindamycin, Trimethoprim, Sulfamethoxazole and Their Transformation Products.” Environmental Pollution, vol. 220, Jan. 2017, pp. 1251–63, https://doi.org/10.1016/j.envpol.2016.11.007. Lell, Bertrand, and Peter G. Kremsner. “Clindamycin as an Antimalarial Drug: Review of Clinical Trials.” Antimicrobial Agents and Chemotherapy, vol. 46, no. 8, Aug. 2002, pp. 2315–20, https://doi.org/10.1128/aac.46.8.2315-2320.2002. |
